Ginkgo Bioworks Holdings (DNA) Equity Income: 2020-2023
Historic Equity Income for Ginkgo Bioworks Holdings (DNA) over the last 3 years, with Dec 2023 value amounting to -$1.1 million.
- Ginkgo Bioworks Holdings' Equity Income fell 111.19% to -$1.1 million in Q4 2023 from the same period last year, while for Dec 2023 it was $7.4 million, marking a year-over-year increase of 116.84%. This contributed to the annual value of -$2.6 million for FY2023, which is 93.98% up from last year.
- Ginkgo Bioworks Holdings' Equity Income amounted to -$1.1 million in Q4 2023, which was down 1,570.15% from -$67,000 recorded in Q2 2023.
- In the past 5 years, Ginkgo Bioworks Holdings' Equity Income registered a high of $10.0 million during Q4 2022, and its lowest value of -$39.7 million during Q3 2021.
- Over the past 3 years, Ginkgo Bioworks Holdings' median Equity Income value was -$4.7 million (recorded in 2021), while the average stood at -$11.2 million.
- As far as peak fluctuations go, Ginkgo Bioworks Holdings' Equity Income tumbled by 16,630.38% in 2021, and later skyrocketed by 314.52% in 2022.
- Over the past 4 years, Ginkgo Bioworks Holdings' Equity Income (Quarterly) stood at $1.8 million in 2020, then plummeted by 365.70% to -$4.7 million in 2021, then surged by 314.52% to $10.0 million in 2022, then tumbled by 111.19% to -$1.1 million in 2023.
- Its last three reported values are -$1.1 million in Q4 2023, -$67,000 for Q2 2023, and -$1.4 million during Q1 2023.